Trials / Completed
CompletedNCT01367561
Naloxone and Intravenous Methylnaltrexone Effects on Bladder Function
A Phase I Urodynamic Study of the Opioid Antagonist, Naloxone and Intravenous Methylnaltrexone Reverse Opioid Effects on Bladder Function in Healthy Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 15 (actual)
- Sponsor
- Bausch Health Americas, Inc. · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
This is a double-blind, randomized, study at a single clinical site investigating the effect of methylnaltrexone and naloxone versus placebo in healthy males who have received a short-acting opioid, remifentanil.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Naloxone | |
| DRUG | IV Methylnaltrexone (MNTX) | |
| DRUG | Placebo |
Timeline
- Start date
- 2002-10-01
- Primary completion
- 2003-05-01
- Completion
- 2003-05-01
- First posted
- 2011-06-07
- Last updated
- 2023-04-12
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01367561. Inclusion in this directory is not an endorsement.